Oral Answers to Questions Debate
Full Debate: Read Full DebateAndrew Stephenson
Main Page: Andrew Stephenson (Conservative - Pendle)Department Debates - View all Andrew Stephenson's debates with the Department of Health and Social Care
(11 months, 3 weeks ago)
Commons ChamberWe recognise that body-wide symptoms associated with Ehlers-Danlos syndrome and hypermobility spectrum disorder can be disabling and can affect all aspects of life. General rheumatology services, which support people with Ehlers-Danlos syndrome and hypermobility spectrum disorder, are locally commissioned by integrated care boards, which are best placed to make decisions according to local need. The major conditions strategy will focus on six groups of conditions, including musculoskeletal disorders such as these syndromes and disorders.
That is all very well, but I do not think that will convince my constituents or the one in 500 people who suffer from that awful disease. This wonderful talented group of people on the Treasury Bench obviously inhabit an alternate universe. My GP said that these days there is no training or research, and that we do not have the capacity to look into these things. People with EDS have to be assessed by uptrained GPs, but they are not there. Our GP and medical services are on their knees. When will the Minister wake up to that fact?
With respect, the hon. Gentleman is as wrong as usual. NHS England is taking forward work to improve the ways in which services for rare diseases are commissioned, putting patients’ voices at the centre of service delivery and ensuring co-ordinated access to specialist care, treatment, drugs, social care, mental health and special educational support. We will continue to work to improve services in this area.
I understand the hon. Lady’s concern. As she knows, we share a local NHS hospital trust. I am very keen to work with her on this issue. Of course, this Government are the first to introduce a long-term workforce plan for the NHS, which will deliver thousands more clinicians for a range of services across the NHS in the years to come.
Last month, the National Institute for Health and Care Excellence said that Kaftrio, Orkambi and Symkevi are effective treatments against cystic fibrosis, but are too expensive to put on the NHS’s list. CF is a death sentence, so what can the Secretary of State do to make sure that this medication is put on the shelves to save thousands of lives in the future?
My hon. Friend makes a very important point. NICE has yet to publish its final guidance and is continuing to work with all parties to address the issues raised in the draft guidance. The Government encourage manufacturers to work with NICE in setting a price that represents value for the NHS. I can assure the House that existing and new patients who are started on treatment while the NICE evaluation is ongoing will have access after it has issued its final recommendations, irrespective of the outcome.
Lobular breast cancer treatment must be improved. Will the Minister meet my constituent and me to discuss how?
Cancer remains the leading cause of death by disease in children and young people, with nearly 500 dying every single year, yet the Government continue to reject calls for a dedicated children’s cancer plan. Why is that?
As the hon. Member knows, cancer will be part of the Government’s long-term strategy for diseases. Improving cancer treatment wait times is a top priority for the Government, with a key focus on the elective care recovery plan backed by an additional £8 billion in revenue funding across the spending review period.
In response to a written question that I submitted, I was told that the Department of Health and Social Care holds no central data for diagnosis and treatment of those with eating disorders and has no idea how many mental health nurse appointments are available in GP surgeries, despite all the funding. Do Ministers agree that that is a disgrace?
My constituent Air Marshal Dr David Walker, an inspirational leader and academic, sadly died of glioblastoma in June. When diagnosed, he and his wife Catherine were shocked to learn of the woefully low funding for brain and other less survivable cancers and established the charity the Right to Hope with Cancer. Will the Minister show the courage and leadership so epitomised by the life of Air Marshal Walker, and properly resource and fund less survivable cancers, so that everyone living with cancer has some sort of hope?
The hon. Gentleman makes an important point. My 23-year-old constituent Laura Nuttall, from Barrowford, died in May, five years after being diagnosed with a glioblastoma, having been given just a year to live. Before her diagnosis, Laura did work experience in my parliamentary and constituency offices. She was one of the most remarkable people I have ever met. As I get up to speed in my new ministerial role, he can rest assured that I will make as much progress as possible in this area. It is a personal priority to me.